Gemini Therapeutics Price on May 7, 2021

GMTXDelisted Stock  USD 17.95  0.05  0.28%   
If you're considering investing in Gemini Stock, it is important to understand the factors that can impact its price. As of today, the current price of Gemini Therapeutics stands at 17.95, as last reported on the 28th of March, with the highest price reaching 19.20 and the lowest price hitting 16.05 during the day. We have found twenty-nine technical indicators for Gemini Therapeutics, which you can use to evaluate the volatility of the firm. Please check out Gemini Therapeutics' Risk Adjusted Performance of 0.0455, market risk adjusted performance of (0.34), and Downside Deviation of 5.65 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Gemini Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
GMTX
Based on monthly moving average Gemini Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gemini Therapeutics by adding Gemini Therapeutics to a well-diversified portfolio.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About Gemini Therapeutics Stock history

Gemini Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gemini is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gemini Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gemini Therapeutics stock prices may prove useful in developing a viable investing in Gemini Therapeutics
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration . Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts. Gemini Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.

Gemini Therapeutics Stock Technical Analysis

Gemini Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Gemini Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Gemini Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Gemini Therapeutics Period Price Range

Gemini Therapeutics March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Gemini Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gemini Therapeutics shares will generate the highest return on investment. By undertsting and applying Gemini Therapeutics stock market strength indicators, traders can identify Gemini Therapeutics entry and exit signals to maximize returns

Gemini Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Gemini Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Gemini Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gemini to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in Gemini Stock

If you are still planning to invest in Gemini Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gemini Therapeutics' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Transaction History
View history of all your transactions and understand their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings